ES2103871T3 - Medicamento para oftalmologia y su empleo. - Google Patents

Medicamento para oftalmologia y su empleo.

Info

Publication number
ES2103871T3
ES2103871T3 ES92120354T ES92120354T ES2103871T3 ES 2103871 T3 ES2103871 T3 ES 2103871T3 ES 92120354 T ES92120354 T ES 92120354T ES 92120354 T ES92120354 T ES 92120354T ES 2103871 T3 ES2103871 T3 ES 2103871T3
Authority
ES
Spain
Prior art keywords
ophthalmology
employment
medication
type
perfluored
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92120354T
Other languages
English (en)
Inventor
Hasso Prof Dr Meinert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmpur GmbH
Original Assignee
Pharmpur GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmpur GmbH filed Critical Pharmpur GmbH
Application granted granted Critical
Publication of ES2103871T3 publication Critical patent/ES2103871T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

AGENTES DE TRATAMIENTO PARA LA OFTALMOLOGIA, CARACTERIZADOS POR UN COMPUESTO LIQUIDO PERFLUORADO (PERFLUORCARBONO MODIFICADO), DEL TIPO O DEL TIPO
ES92120354T 1992-04-01 1992-11-27 Medicamento para oftalmologia y su empleo. Expired - Lifetime ES2103871T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4210846 1992-04-01
DE4211958A DE4211958A1 (de) 1992-04-01 1992-04-09 Behandlungsmittel für die Augenheilkunde und seine Verwendung

Publications (1)

Publication Number Publication Date
ES2103871T3 true ES2103871T3 (es) 1997-10-01

Family

ID=25913506

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92120354T Expired - Lifetime ES2103871T3 (es) 1992-04-01 1992-11-27 Medicamento para oftalmologia y su empleo.

Country Status (5)

Country Link
US (1) US5441733A (es)
EP (1) EP0563446B1 (es)
AT (1) ATE152909T1 (es)
DE (2) DE4211958A1 (es)
ES (1) ES2103871T3 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
DE19536504C2 (de) * 1995-09-29 1999-09-23 H Meinert Verwendung fluorierter Alkane
DE19719280C1 (de) * 1997-05-07 1998-09-24 Pharm Pur Gmbh Fluorierte Alkane und ihre Verwendungen
DE19811683C2 (de) * 1998-03-18 2000-03-23 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
DE19861012A1 (de) 1998-03-18 1999-09-30 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
DE19926889B4 (de) * 1999-06-12 2005-06-16 Bausch & Lomb Inc. Verwendung eines Gels mit Polyaphronstruktur zur Herstellung eines Implantats
DE19926890C1 (de) * 1999-06-12 2000-07-27 Pharm Pur Gmbh Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
ES2305368T3 (es) * 2002-05-10 2008-11-01 THE PROCTER & GAMBLE COMPANY Tisu estampado en relieve que tiene fibras superficiales sueltas y metodo para su produccion.
CA2568616A1 (en) * 2004-06-01 2005-12-15 The Trustees Of Columbia University In The City Of New York Partially-fluorinated ethers, compositions and uses thereof, for long-term tamponade in the eye
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) * 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
FR2214674A1 (en) * 1973-01-18 1974-08-19 Inst Nat Rech Chimique Trifluoromethyl (oxy) aryl cpds prepn - by reacting chlorides of (thio) acids, or chlorothioformates with molybdenum hexafluorides
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4452818A (en) * 1982-03-19 1984-06-05 Haidt Sterling J Extraocular method of treating the eye with liquid perfluorocarbons
JPS59139252A (ja) * 1982-11-26 1984-08-10 チルドレンズ・ホスピタル・メデイカル・センタ− 眼の眼外処置用装置
FR2623525B1 (fr) * 1987-11-19 1990-03-02 Poudres & Explosifs Ste Nale Procede d'electrosynthese de composes gem di ou tri halogenes
DE3903336A1 (de) * 1989-02-04 1990-08-09 Bayer Ag Verwendung von c(pfeil abwaerts)3(pfeil abwaerts)- bis c(pfeil abwaerts)5(pfeil abwaerts)-polyfluoralkanen als treibgase
DE3925525A1 (de) * 1989-08-02 1991-02-07 Hoechst Ag Verfahren zur herstellung von (alpha),omega-bisperfluoralkylalkanen
DE4100059C2 (de) * 1991-01-03 1994-08-25 Adatomed Pharma & Med Behandlungsflüssigkeit zum Wiederanlegen (Entfalten) abgelöster Netzhaut an die Aderhaut des Auges
DE4101976C2 (de) * 1991-01-24 1995-09-21 Adatomed Pharma Chiron Behandlungssystem für Netzhautentfaltung

Also Published As

Publication number Publication date
DE4211958A1 (de) 1993-10-21
ATE152909T1 (de) 1997-05-15
US5441733A (en) 1995-08-15
EP0563446B1 (de) 1997-05-14
DE59208498D1 (de) 1997-06-19
EP0563446A1 (de) 1993-10-06

Similar Documents

Publication Publication Date Title
DE59006506D1 (de) Transdermale Applikation von 2-Amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol.
FI941452A (fi) Yhdisteitä, jotka lisäävät muiden sytotoksisten aineiden kasvaimenvastaista aktiivisuutta
YU47993B (sh) Derivati 2,4-diaminohinazolina
LV10924A (lv) Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai
IT1276130B1 (it) Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ES2103871T3 (es) Medicamento para oftalmologia y su empleo.
ATE115848T1 (de) Spritzenvorrichtung für flüssigkeitsmischungen, insbesondere für zahnärztliche zwecke.
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
FR2691465B1 (fr) Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ITMI920955A1 (it) Idrogeli di tipo polietereammidoamminico come materiali eparinizzabili
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
ES509570A0 (es) Perfeccionamientos en un dispositivo de aplicacion de un liquido para el tratamiento o la distribuicion de vegetales".
ITMI920979A0 (it) N-acil derivati di aminoalcooli come agenti terapeutici attivi sull'edema neurogenico endoneurale a livello del nervo periferico.
FI894982A0 (fi) Massaaendlaoden foer maskin som tillverkar fiberband, saerskilt pappersband.
IT8819286A0 (it) Procedimento per il trattamento extracorporeo di liquido ascitico.
ES2049711T3 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de cistinuria.
ITMI931622A0 (it) Procedimento e apparecchiatura di trattamento del liquido di bagnatura in macchine da stampa, particolarmente per macchine da stampa offset.
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
SE8802040D0 (sv) New use
DE3880066D1 (de) Optisch aktive fluessigkristallverbindungen und zusammensetzungen, die diese enthalten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563446

Country of ref document: ES